Brief: Purapharm Posts FY Loss Attributable HK$121.9 Mln
29/03/2022 16:29
March 29 (Reuters) - PuraPharm Corp:
* FY LOSS ATTRIBUTABLE HK$121.9 MILLION VERSUS PROFIT OF
HK$31.7
MILLION
* FY REVENUE HK$659.6 MILLION VERSUS HK$601.8 MILLION
Source text for Eikon: ID:nHKS9gqml
Further company coverage: 1498.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PuraPharm
See all newsBrief: Purapharm Corp To Issue Convertible Bonds With Principal Amount Of HK$20 MLN
Brief: Purapharm Corp To Issue Consideration Shares As Licence Fee
Brief: Purapharm Says Kam Biu Tsoi, Alvin Appointed As Executive Director
Brief: Purapharm Corp Announces Lapse Of Disposal Agreement
Brief: PuraPharm Corp To Dispose Of Accounts Receivables At HK$15 Mln